Occurrence and Impact of Urinary Tract Infections: A Case Study from Najaf, Iraq
DOI:
https://doi.org/10.46966/msjar.v7i3.398Keywords:
Antibiotic Resistance, Epidemiology, Public Health, Urinary Tract InfectionAbstract
Urinary tract infections (UTIs) represent among the most widespread bacterial infections affecting populations throughout the world. The incidence rates of urinary tract infections differ according to the location together with population statistics and economic background of the region. This study investigates the epidemiology, risk factors, and antibiotic resistance patterns of UTIs in Najaf, Iraq, The research findings present vital knowledge points which guide better diagnostic methods and treatment approaches. A total of 500 patients receiving UTI diagnoses during the duration from October 2024 to February 2025 entered the research. The investigators performed bacterial pathogen identification tests on collected samples while running susceptibility tests on the identified pathogens. A higher infection rate appeared in female patients from the study data as their UTI occurrence reached 70% against male patients with 30%. The main pathogen involved in UTIs was Escherichia coli which was identified in 56% of cases among 500 diagnosed individuals, (30% were male and 70% were female). Also, research identifies a rising issue of antibiotic resistance when examining UTI treatment effectiveness for ampicillin and trimethoprim. The results demonstrated that nitrofurantoin with Fosfomycin stood as effective treatment alternatives but sulfamethoxazole showed decreased effectiveness. The high prevalence in female UTI cases alongside pathogen identification calls for new treatment guidelines and better education about infections for the population and stricter antibiotic stewardship in the region.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Qasim Najim AlShemmary

This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Medical Science Journal for Advance Research agree to the following terms:
- Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.


















